Related Experiment Videos
Immobilisation hypercalcemia
Mineral and Electrolyte Metabolism
|January 1, 1984
Summary
Immobilisation hypercalcemia in patients may involve biologically inactive parathyroid hormone (PTH). Bone histology varies, and distinguishing it from primary hyperparathyroidism requires careful clinical evaluation.
Area of Science:
- Endocrinology
- Nephrology
- Bone Metabolism
Background:
- Immobilisation hypercalcemia is a complex condition.
- Understanding its biochemical and histological underpinnings is crucial for diagnosis.
Purpose of the Study:
- To investigate the biochemical and bone histological characteristics of patients with immobilisation hypercalcemia.
- To explore the role of parathyroid hormone (PTH) and its potential inactivity.
Main Methods:
- Studied 5 patients with immobilisation hypercalcemia.
- Measured plasma calcium, parathyroid hormone (PTH), and nephrogenous cyclic adenosine monophosphate (cAMP).
- Performed quantitative bone histology.
Main Results:
- Elevated plasma calcium levels were observed.
- Elevated or inappropriately detectable PTH levels were noted in most patients.
- Bone histology showed variable patterns, including increased resorption and altered bone formation rates.
Conclusions:
- PTH may be biologically inactive in immobilisation hypercalcemia, with elevations potentially due to renal retention of fragments.
- Bone histological findings are variable and not correlated with illness duration.
- Clinical assessment is vital to differentiate from primary hyperparathyroidism.